**AI驱动的病理学云平台Proscia完成900万美元C+轮融资**
领先的数字病理学软件供应商Proscia今日宣布，成功在C+轮融资中募集900万美元，使得该轮融资的总金额达到了4600万美元。本轮融资由Highline Capital Management和Triangle Peak Partners两家投资机构领投，同时获得了包括Alpha Intelligence Capital、Scale Venture Partners以及Hitachi Ventures等现有投资者的积极参与。
这笔资金的注入将主要用于推动Proscia的商业扩张，以及加速其在生命科学和诊断实验室领域的人工智能应用程序的研发。Proscia的平台利用人工智能技术，革新了病理学的研究和诊断流程，提高了病理学家的工作效率和诊断准确性。
Proscia的这一轮融资标志着其在数字化病理学领域的持续领导地位，同时也反映出投资者对AI在医疗健康领域应用的强烈信心。随着资金的到位，Proscia有望进一步扩大市场份额，为全球的医疗机构和研究机构提供更为先进和智能化的病理学解决方案。
英语如下：
**AI-Powered Pathology Platform Proscia Secures $9 Million in C+ Funding Round**
Leading digital pathology software provider Proscia has announced the completion of a $9 million C+ funding round, bringing the total raised in this round to $46 million. The round was led by Highline Capital Management and Triangle Peak Partners, with strong participation from existing investors, including Alpha Intelligence Capital, Scale Venture Partners, and Hitachi Ventures.
The fresh funding will primarily fuel Proscia’s commercial expansion and accelerate the development of its artificial intelligence (AI) applications in the life sciences and diagnostic laboratory sectors. Proscia’s platform, leveraging AI, revolutionizes pathology research and diagnostic processes, enhancing pathologists’ efficiency and diagnostic accuracy.
This latest funding round underscores Proscia’s ongoing leadership in digital pathology and reflects the strong investor confidence in the application of AI in healthcare. With the new capital, the company is poised to expand its market presence and deliver more advanced, AI-enabled pathology solutions to healthcare institutions and research facilities worldwide.
【来源】https://venturebeat.com/ai/proscias-46m-series-c-propels-ai-driven-pathology-into-the-mainstream/
Views: 1